Spectrum Library
-
Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge
-
Neuromyelitis optica spectrum disorder Patient experience and quality of life
-
Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders
-
Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry
-
The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began.
-
Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.
-
Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques
-
Early B cell tolerance defects in NMO favour anti-AQP4 autoantibody production
-
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.
-
Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.
-
Rituximab in neurological disease: principles, evidence and practice.
-
MOG-IgG-associated disease has a stereotypical clinical course, asymptomatic visual impairment and good treatment response